Bringing Insights to Life

Interpace Biosciences® (IDXG) is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer.

Learn More

IMPORTANT UPDATE

PancraGEN® and Fluid Chemistry Tests for Amylase, CEA, and Glucose Continue to be Available

View Details

Latest News

Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results

Interpace Biosciences Releases Preliminary Record Second Quarter 2023 Business Results; Updates Status of PancraGEN® Reimbursement

Interpace Expects to Stop Offering PancraGEN® Test Due to CMS Decision to End Reimbursement as of July 17, 2023
View all news

Sign up for Email Alerts

Stay informed and receive company updates straight to your inbox.

Sign up today

Stock Information

Day Range
52 Week Range
View Investor Relations